
At AaviGen we are dedicated to advancing heart-specific gene therapies through our unique Adeno-Associated Viral (AAV) vector platform. Our mission is to deliver precise, safe treatments that address the core molecular causes of heart failure, bringing transformative solutions to patients worldwide. With a focus on cardiac innovation, we strive to make a meaningful impact on global heart health by developing therapies tailored to individual patient needs. Explore more about our work at aavigen.com #GeneTherapy #HeartHealth #Innovation #Biotech #PrecisionMedicine #HeartFailure #AAV #Technology…
Annual Revenue$10M to $25M
Estimated OwnershipPrivateBuilt from contact records that share this company: name, job title, job level, job function and person location.
Turn cold outreach into meaningful business conversations.
Rated and recommended by professionals who expect more
Matching runs on fields we already have: industry, employee range, HQ location, ownership type, funding rounds, specialities. Results come live from the ReachStream directory.